Global Diabetic Foot Ulcer Market, 2021-2027

February 2022 | 74 pages | ID: G44FB1256B0BEN
Gen Consulting Company

Abstracts

Foot ulcers are a common complication of diabetes that is not being managed through methods such as diet, exercise, and insulin treatment. The pathogenesis of foot ulceration is complex, clinical presentation variable, and management requires early expert assessment. According to Gen Consulting Company, the global diabetic foot ulcer market is projected to reach USD 5,388 million, recording a CAGR of approximately 5.7 percent from 2021 to 2027.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global diabetic foot ulcer market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The diabetic foot ulcer market is segmented on the basis of product, ulcer type, end user, and region. The diabetic foot ulcer market is segmented as below:

By product:

• advanced wound dressings
• biologics
• therapy device

By ulcer type:

• ischemic ulcers
• neuro-ischemic ulcers
• neuropathic ulcers

By end user:

• ambulatory surgery centers (ASCs)
• home care
• hospitals

By region:

• region
• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The global diabetic foot ulcer market report offers detailed information on several market vendors, including Acelity L.P. Inc., B. Braun Melsungen AG, BSN Medical GMBH, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group plc, Medline Industries, Inc., M?lnlycke Health Care AB., Organogenesis Inc., Smith & Nephew PLC, The 3M Company, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global diabetic foot ulcer market.
• To classify and forecast the global diabetic foot ulcer market based on product, ulcer type, end user, and region.
• To identify drivers and challenges for the global diabetic foot ulcer market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global diabetic foot ulcer market.
• To identify and analyze the profile of leading players operating in the global diabetic foot ulcer market.

Why Choose This Report

• Gain a reliable outlook of the global diabetic foot ulcer market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR DIABETIC FOOT ULCER BY PRODUCT

5.1 Advanced wound dressings
  5.1.1 Market size and forecast
5.2 Biologics
  5.2.1 Market size and forecast
5.3 Therapy device
  5.3.1 Market size and forecast

PART 6. GLOBAL MARKET FOR DIABETIC FOOT ULCER BY ULCER TYPE

6.1 Ischemic ulcers
  6.1.1 Market size and forecast
6.2 Neuro-ischemic ulcers
  6.2.1 Market size and forecast
6.3 Neuropathic ulcers
  6.3.1 Market size and forecast

PART 7. GLOBAL MARKET FOR DIABETIC FOOT ULCER BY END USER

7.1 Ambulatory surgery centers (ASCs)
  7.1.1 Market size and forecast
7.2 Home care
  7.2.1 Market size and forecast
7.3 Hospitals
  7.3.1 Market size and forecast

PART 8. GLOBAL MARKET FOR DIABETIC FOOT ULCER BY REGION

8.1 Asia Pacific
  8.1.1 Market size and forecast
8.2 Europe
  8.2.1 Market size and forecast
8.3 North America
  8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
  8.4.1 Market size and forecast

PART 9. KEY COMPETITOR PROFILES

9.1 Acelity L.P. Inc.
9.2 B. Braun Melsungen AG
9.3 BSN Medical GMBH
9.4 Cardinal Health, Inc.
9.5 Coloplast A/S
9.6 ConvaTec Group plc
9.7 Medline Industries, Inc.
9.8 M?lnlycke Health Care AB.
9.9 Organogenesis Inc.
9.10 Smith & Nephew PLC
9.11 The 3M Company
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY